Management of thyroid ophthalmopathy

Area of Science:

• Ophthalmology
• Endocrinology
• Thyroidology

Background:

• The pathogenesis of thyroid ophthalmopathy (TO) and its link to thyroid dysfunction remain unclear.
• Current therapeutic strategies for TO are primarily palliative.
• The impact of antithyroid therapy on the progression of thyroid eye disease is a subject of ongoing debate.

Purpose of the Study:

• To review the current understanding of thyroid ophthalmopathy pathogenesis and treatment.
• To highlight emerging and established therapeutic modalities for thyroid eye disease.
• To identify areas requiring further investigation in TO management.

Main Methods:

• Review of existing literature on thyroid ophthalmopathy.
• Analysis of current and investigational treatment approaches.
• Synthesis of findings regarding surgical and medical interventions.

Main Results:

• The underlying mechanisms of TO are not fully understood.
• Corticosteroids and radiation therapy are being investigated for patient-specific efficacy.
• Surgical innovations in eyelid retraction, orbital decompression, and myopathy treatment improve outcomes.
• Octreotide shows preliminary potential for TO treatment and prevention.

Conclusions:

• Effective treatments for thyroid ophthalmopathy are limited due to incomplete understanding of its pathogenesis.
• Further research is essential to address fundamental questions regarding TO treatment and prevention.
• A combination of medical, surgical, and potentially novel agents like octreotide may offer future therapeutic avenues.